ATAI Life Sciences Files 8-K with Financials

Ticker: ATAI · Form: 8-K · Filed: Jun 5, 2024 · CIK: 1840904

Atai Life Sciences N.V. 8-K Filing Summary
FieldDetail
CompanyAtai Life Sciences N.V. (ATAI)
Form Type8-K
Filed DateJun 5, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: financial-statements, exhibits, reporting

TL;DR

ATAI Life Sciences filed an 8-K with financials, no major news.

AI Summary

On June 5, 2024, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The company is incorporated in the Netherlands and has its principal executive offices in Berlin, Germany.

Why It Matters

This filing indicates that ATAI Life Sciences is fulfilling its reporting obligations by submitting financial statements and exhibits, which is standard procedure for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a routine submission of financial statements and exhibits, not indicating any new risks or significant events.

Key Players & Entities

  • ATAI Life Sciences N.V. (company) — Registrant
  • June 5, 2024 (date) — Date of report
  • The Netherlands (jurisdiction) — State of incorporation
  • Berlin, Germany (location) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report financial statements and exhibits.

What is the exact name of the registrant?

The exact name of the registrant is ATAI Life Sciences N.V.

In which jurisdiction is ATAI Life Sciences N.V. incorporated?

ATAI Life Sciences N.V. is incorporated in The Netherlands.

Where are the principal executive offices of ATAI Life Sciences N.V. located?

The principal executive offices of ATAI Life Sciences N.V. are located in Berlin, Germany.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is June 5, 2024.

Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 9.4 · Accepted 2024-06-05 08:00:49

Filing Documents

01

Item 8.01 Other Events. On June 5, 2024, atai Life Sciences N.V. (the "Company") posted to the Company's corporate website at www.atai.life an investor presentation (the "Investor Presentation") to be used from time to time in meetings with investors and analysts. A copy of the Investor Presentation is attached as Exhibit 99.1 and is incorporated herein by reference.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Investor Presentation, dated June 5, 2024. 104 Cover Page Interactive Data File (embedded within the inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATAI LIFE SCIENCES N.V. Date: June 5, 2024 By: /s/ Florian Brand Name: Florian Brand Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.